Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Time to stop mammography screening?

Literature DB >> 22106102

Time to stop mammography screening?

Peter C Gøtzsche¹.

Abstract

Mesh：

Year: 2011 PMID： 22106102 PMCID： PMC3225414 DOI： 10.1503/cmaj.111721

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

11 in total

Review 1. Why mammography screening has not lived up to expectations from the randomised trials.

Authors: Peter C Gøtzsche; Karsten Juhl Jørgensen; Per-Henrik Zahl; Jan Mæhlen
Journal: Cancer Causes Control Date: 2011-11-10 Impact factor: 2.506

2. Recommendations on screening for breast cancer in average-risk women aged 40-74 years.

Authors: Marcello Tonelli; Sarah Connor Gorber; Michel Joffres; James Dickinson; Harminder Singh; Gabriela Lewin; Richard Birtwhistle; Donna Fitzpatrick-Lewis; Nicole Hodgson; Donna Ciliska; Mary Gauld; Yan Yun Liu
Journal: CMAJ Date: 2011-11-22 Impact factor: 8.262

3. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality?

Authors: Karsten Juhl Jørgensen; John D Keen; Peter C Gøtzsche
Journal: Radiology Date: 2011-09 Impact factor: 11.105

4. Breast cancer screening with mammography: overview of Swedish randomised trials.

Authors: L Nyström; L E Rutqvist; S Wall; A Lindgren; M Lindqvist; S Rydén; I Andersson; N Bjurstam; G Fagerberg; J Frisell
Journal: Lancet Date: 1993-04-17 Impact factor: 79.321

5. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.

Authors: Per-Henrik Zahl; Peter C Gøtzsche; Jan Mæhlen
Journal: Lancet Oncol Date: 2011-10-11 Impact factor: 41.316

6. Breast cancer mortality in organised mammography screening in Denmark: comparative study.

Authors: Karsten Juhl Jørgensen; Per-Henrik Zahl; Peter C Gøtzsche
Journal: BMJ Date: 2010-03-23

7. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database.

Authors: Philippe Autier; Mathieu Boniol; Carlo La Vecchia; Carlo LaVecchia; Lars Vatten; Anna Gavin; Clarisse Héry; Mary Heanue
Journal: BMJ Date: 2010-08-11

Review 8. Screening for breast cancer with mammography.

Authors: Peter C Gøtzsche; Margrethe Nielsen
Journal: Cochrane Database Syst Rev Date: 2009-10-07

9. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.

Authors: Philippe Autier; Mathieu Boniol; Anna Gavin; Lars J Vatten
Journal: BMJ Date: 2011-07-28

9. Comparative benefit from small tumour size and adjuvant chemotherapy: clues for explaining breast cancer mortality decline.

Authors: Romano Demicheli; Federico Ambrogi
Journal: BMC Cancer Date: 2014-09-24 Impact factor: 4.430

9 in total

Time to stop mammography screening?

Review 1. Why mammography screening has not lived up to expectations from the randomised trials.

2. Recommendations on screening for breast cancer in average-risk women aged 40-74 years.

3. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality?

4. Breast cancer screening with mammography: overview of Swedish randomised trials.

5. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.

6. Breast cancer mortality in organised mammography screening in Denmark: comparative study.

7. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database.

Review 8. Screening for breast cancer with mammography.

9. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.

Review 10. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.

1. CJS debate: Is mammography useful in average-risk screening for breast cancer?

2. Response to: "Beyond the mammography debate: a moderate perspective".

3. Breast cancer screening panels continue to confuse the facts and inject their own biases.

4. Screening Mammography Among Older Women: A Review of United States Guidelines and Potential Harms.

5. Overdiagnosing overdiagnosis.

6. Arguments against mammography screening continue to be based on faulty science.

Review 7. Implications of Overdiagnosis: Impact on Screening Mammography Practices.

8. Do not jump too quickly to conclusions.

9. Comparative benefit from small tumour size and adjuvant chemotherapy: clues for explaining breast cancer mortality decline.